Overview
Inovintell develops AI-based solutions for the life sciences industry, supporting the development and evaluation of medical products. Its NaviHTA™ platform supports health technology assessment and market access planning, drawing on expertise in machine learning, natural language processing, data analytics, and life sciences.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Workshop at the IMAS conference
InovIntell was at the ACCESS 2023 conference in Miami, from 3 to 5 April. We presented a couple of our ongoing projects in front of a highly engaged audience during the workshop: “How artificial intelligence will reshape market access”. Here you will find the slide deck.
InovIntell Tunisian office speedily going live
InovIntell Tunisian office speedily going live with aggressive hiring strategy.
We are celebrating the start of business in Krakow!
Szymon Maszke and Mondher Toumi are celebrating the start of business in Krakow!
We are preparing the opening of a new office in Tunis!
Samuel Aballéa and Mondher Toumi in Tunis, to prepare the opening of a new office.
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-09-07. Active
03 1050 1445 1000 0090 3283 2439- 78 1050 1445 1000 0090 3283 2447
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Inovintell holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2024.
| Mark | Protected until | |
|---|---|---|
| NaviHTA | Sep 25, 2034 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to perform legal acts in the name of the company independently and without limitations.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Invest Value S.a.r.l. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aurevia Polandsp. z o.o. | $1,330,077.42 | aurevia.com | ||
| Saventic Healthsp. z o.o. | $1,089,246.05 | saventic.com | ||
| Indoornavisp. z o.o. | $932,972.68 | indoornavi.me | ||
| CTI Clinical Trial and Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Active Textsp. z o.o. | $409,418.80 | active-text.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Innovatronicasp. z o.o. | $269,189.12 | inowatronika.com | ||
| JAS Analyticssp. z o.o. | $245,699.54 | jasanalytics.eu | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| IntelliseqS.A. | $156,552.76 | intelliseq.pl |
FAQ
Last updated: 2026-07-09